Global Market for Cold Plasma in Healthcare is Anticipated to grow at a Significant Pace i.e., at a 12.5% CAGR during 2023-2030

Published Date: Jun, 2023

During the projected period 2023-2030, the cold plasma in the healthcare market is expected to increase at a CAGR of 12.5% owing to the advantages associated with cold plasma techniques and the increasing usage of cold plasma in wound healing, the market is likely to increase rapidly. Cold plasma is an ionized gas that forms at room temperature as a result of an electric discharge. Cold plasma treatment is a painless and contact-free way to sterilize wounds and aid in wound healing. The costs are comparable to or less than those associated with standard antimicrobial wound treatment. Cold plasma has the potential to destroy bacteria and prevent infections, and it has been shown to be effective in treating burns, therefore the field of cold plasma in medicine is rapidly expanding.

In January 2022, PLASMITEC is the trademark name for WACKER's platform for generating and producing plasmid DNA (pDNA). At the newly purchased San Diego location, the exclusive technology platform is based on decades of experience in pDNA manufacture. It can be utilized in research, clinical development, and commercial manufacture.  pDNA is the foundation for a wide range of novel therapeutic agents, and demand for these products is growing. As part of efforts to design and manufacture mRNA-based vaccines for COVID-19, demand for pDNA has risen dramatically recently.

Browse 43 market data Tables and 30 Figures spread through 250 Pages and in-depth TOC on " Cold Plasma in Healthcare Market by Regime Type (Low Pressure and Atmospheric Pressure), by Application (Wound Healing, Cancer Treatment, Dentistry, Blood Coagulation and Others), and Region - Global Forecast to 2030"

By application, wound healing segment is anticipated to have a highest CAGR during the forecast period.

Based on application, the cold plasma in healthcare market is divided into wound healing, blood coagulation, dentistry, cancer treatment, and others. The wound healing segment is projected to have a high CAGR during the forecast period owing to the benefits of cold plasma treatment, offers safety from microbial infections, minimal-side effects and more viable than conventional methods, resulting in growth of the cold plasma market. The increased incidences of trauma, accidents, and wound management globally will drive the demand for cold plasma in the healthcare facilities.

Global Cold Plasma in Healthcare Market Segmentation Analysis

Segment

Categorization

Leading Category

Regime Type

Low Pressure and Atmospheric Pressure

Atmospheric Pressure (Largest)

Application

Wound Healing, Cancer Treatment, Dentistry, Blood Coagulation and Others

Wound Healing (Largest)

Region

North America, Europe, Asia-Pacific, and Rest of the World

North America (Largest)

Asia-Pacific

 (High CAGR)

Discover More About This Report, Download A Free Sample Copy of Cold Plasma in Healthcare Market

“Asia-Pacific is anticipated to have a high CAGR in cold plasma healthcare market during 2023-2030.”

Asia-Pacific is anticipated to have a high CAGR during the forecast period owing to the rising demand for cold plasma technology and industry players emphasizing to develop and expand their research and development activities and improved distribution network in the region. Furthermore, the increasing disposable income and rising target population base will further drive the demand for cold plasma in the healthcare market in the APAC region.

Some of the major players in the global cold plasma in healthcare market include US Medical Innovations, RELYON PLASMA GMBH, neoplas GmbH, Europlasma NV, P2i Ltd, Wacker Chemie AG, ADTEC Plasma Technology co., ltd., terraplasma medical GmbH (Acquired by Viromed Group), Coldplasmatech GmbH, and Apyx Medical

Scope of the Report

Report Metric

Details

Market Size Available for the Years in the Study

2018–2030

Historical Period

2018–2030

Base Year

2022

Forecast Period

2023–2030

Segments Covered in the Study

Regime Type, Application, and Region

Geographies Covered in the Study

North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, Spain, Russia), Asia-Pacific (China, Japan, India, South Korea), and Rest of the World (Brazil, Saudi Arabia, South Africa, U.A.E.)

Companies Covered in the Study

US Medical Innovations, RELYON PLASMA GMBH, neoplas GmbH, Europlasma NV, P2i Ltd, Wacker Chemie AG, ADTEC Plasma Technology co.,ltd., terraplasma medical GmbH (Acquired by Viromed Group), Coldplasmatech GmbH,  and Apyx Medical

Global Cold Plasma in Healthcare Market Coverage

Regime Type Insight and Forecast 2018-2030

  • Low Pressure
  • Atmospheric Pressure

Application Insight and Forecast 2018-2030

  • Wound Healing
  • Cancer Treatment
  • Dentistry
  • Blood Coagulation
  • Others

Geographical Segmentation

Cold Plasma in Healthcare Market by Region

North America

  • By Regime Type
  • By Application
  • By Country – U.S., Canada, and Mexico

Europe

  • By Regime Type
  • By Application
  • By Country – Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe

Asia-Pacific (APAC)

  • By Regime Type
  • By Application
  • By Country – China, Japan, India, South Korea, and Rest of Asia-Pacific

Rest of the World (RoW)

  • By Regime Type
  • By Application
  • By Country – Brazil, Saudi Arabia, South Africa, U.A.E., and Other Countries